Royalty Pharma Business Segments

Business, geographic, and product segment breakdowns

Royalty Pharma generates $2.4B in annual revenue across 2 key segments: Income from financial royalty assets ($2.3B), and Other royalty income and revenues ($123.9M). The company-wide operating margin is 65.08%. Based on the Q1 2026 filing.